Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Sagel SD, Chmiel JF, Konstan MW.

Proc Am Thorac Soc. 2007 Aug 1;4(4):406-17. Review.

2.

Noninvasive biomarkers of airway inflammation in cystic fibrosis.

Sagel SD.

Curr Opin Pulm Med. 2003 Nov;9(6):516-21. Review.

PMID:
14534405
3.

Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.

Sagel SD, Wagner BD, Anthony MM, Emmett P, Zemanick ET.

Am J Respir Crit Care Med. 2012 Nov 1;186(9):857-65. doi: 10.1164/rccm.201203-0507OC. Epub 2012 Aug 16.

4.

Sputum trace metals are biomarkers of inflammatory and suppurative lung disease.

Gray RD, Duncan A, Noble D, Imrie M, O'Reilly DS, Innes JA, Porteous DJ, Greening AP, Boyd AC.

Chest. 2010 Mar;137(3):635-41. doi: 10.1378/chest.09-1047. Epub 2009 Oct 3.

PMID:
19801580
5.

Sputum proteomics in inflammatory and suppurative respiratory diseases.

Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, Innes JA, Porteous DJ, Greening AP.

Am J Respir Crit Care Med. 2008 Sep 1;178(5):444-52. doi: 10.1164/rccm.200703-409OC. Epub 2008 Jun 19.

6.

Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.

Sloane AJ, Lindner RA, Prasad SS, Sebastian LT, Pedersen SK, Robinson M, Bye PT, Nielson DW, Harry JL.

Am J Respir Crit Care Med. 2005 Dec 1;172(11):1416-26. Epub 2005 Sep 15.

PMID:
16166615
7.

Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.

Sagel SD, Sontag MK, Wagener JS, Kapsner RK, Osberg I, Accurso FJ.

J Pediatr. 2002 Dec;141(6):811-7.

PMID:
12461498
8.

Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.

Liou TG, Adler FR, Keogh RH, Li Y, Jensen JL, Walsh W, Packer K, Clark T, Carveth H, Chen J, Rogers SL, Lane C, Moore J, Sturrock A, Paine R 3rd, Cox DR, Hoidal JR.

PLoS One. 2012;7(8):e42748. doi: 10.1371/journal.pone.0042748. Epub 2012 Aug 10.

9.

Pulmonary biomarkers in chronic obstructive pulmonary disease.

Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, Saetta M.

Am J Respir Crit Care Med. 2006 Jul 1;174(1):6-14. Epub 2006 Mar 23. Review.

PMID:
16556692
10.

Extracellular purines are biomarkers of neutrophilic airway inflammation.

Esther CR Jr, Alexis NE, Clas ML, Lazarowski ER, Donaldson SH, Ribeiro CM, Moore CG, Davis SD, Boucher RC.

Eur Respir J. 2008 May;31(5):949-56. doi: 10.1183/09031936.00089807. Epub 2008 Feb 6.

11.

Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.

Laguna TA, Williams CB, Brandy KR, Welchlin-Bradford C, Moen CE, Reilly CS, Wendt CH.

J Cyst Fibros. 2015 May;14(3):334-40. doi: 10.1016/j.jcf.2014.10.002. Epub 2014 Oct 23.

12.

Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection.

Chirico V, Lacquaniti A, Leonardi S, Grasso L, Rotolo N, Romano C, Di Dio G, Lionetti E, David A, Arrigo T, Salpietro C, La Rosa M.

Clin Microbiol Infect. 2015 Apr;21(4):368.e1-9. doi: 10.1016/j.cmi.2014.11.004. Epub 2014 Nov 15.

13.
14.

Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis.

Pauwels A, Decraene A, Blondeau K, Mertens V, Farre R, Proesmans M, Van Bleyenbergh P, Sifrim D, Dupont LJ.

Chest. 2012 Jun;141(6):1568-74. doi: 10.1378/chest.11-1573. Epub 2011 Dec 1.

PMID:
22135379
15.

Markers of airway inflammation in pulmonary diseases assessed by induced sputum.

Dragonieri S, Tongoussouva O, Zanini A, Imperatori A, Spanevello A.

Monaldi Arch Chest Dis. 2009 Sep;71(3):119-26. Review.

PMID:
19999958
16.

The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis.

Goeminne PC, Vandooren J, Moelants EA, Decraene A, Rabaey E, Pauwels A, Seys S, Opdenakker G, Proost P, Dupont LJ.

Respirology. 2014 Feb;19(2):203-10. doi: 10.1111/resp.12219. Epub 2013 Nov 29.

17.

[Examination of exhaled breath condensate in cystic fibrosis].

Fila L, Musil J.

Cas Lek Cesk. 2010;149(4):173-7. Review. Czech.

PMID:
20518250
18.

Induced sputum: a window to lung pathology.

Nicholas B, Djukanović R.

Biochem Soc Trans. 2009 Aug;37(Pt 4):868-72. doi: 10.1042/BST0370868. Review.

PMID:
19614609
19.

Association between pulmonary function and sputum biomarkers in cystic fibrosis.

Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW.

Am J Respir Crit Care Med. 2007 Apr 15;175(8):822-8. Epub 2007 Jan 18.

20.

Use of ibuprofen to assess inflammatory biomarkers in induced sputum: Implications for clinical trials in cystic fibrosis.

Chmiel JF, Konstan MW, Accurso FJ, Lymp J, Mayer-Hamblett N, VanDevanter DR, Rose LM, Ramsey BW; Assessment of Induced Sputum in Cystic Fibrosis Study Group..

J Cyst Fibros. 2015 Nov;14(6):720-6. doi: 10.1016/j.jcf.2015.03.007. Epub 2015 Apr 11.

PMID:
25869324

Supplemental Content

Support Center